K. Dawson

发表

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS).

J. Friedberg, C. Flowers, J. Hainsworth, 2015, Blood.

Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States

D. Veenstra, G. Guzauskas, P. Thuresson, 2019, Leukemia & lymphoma.

[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice

A. Zelenetz, J. Friedberg, C. Flowers, 2017, Leukemia & lymphoma.

Rituximab Faster Infusion for Patients With Non-Hodgkin's Lymphoma in the United States: Implications for Nursing Practice.

K. Dawson, 2013, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.

J. Cerhan, A. Zelenetz, J. Friedberg, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.

J. Cerhan, A. Zelenetz, J. Friedberg, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study

J. Cerhan, A. Zelenetz, J. Friedberg, 2019, British journal of haematology.

Maintenance rituximab in Veterans with follicular lymphoma

B. Sauer, A. Halwani, K. Dawson, 2020, Cancer medicine.

Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry

M. Lacouture, A. Sekulic, A. Chang, 2022, PloS one.

Determination of locally advanced basal cell carcinoma (BCC) in the first 285 patients enrolled in the RegiSONIC disease registry study.

T. Olencki, M. Lacouture, A. Sekulic, 2015 .

3332 Real-world treatment of vismodegib (VISMO)-related adverse events (AEs) in patients with locally advanced basal cell carcinoma: Report from the RegiSONIC Disease Registry Study

T. Olencki, M. Lacouture, A. Sekulic, 2015 .

Outcomes following watchful waiting for stage II–IV follicular lymphoma patients in the modern era

J. Cerhan, J. Friedberg, C. Flowers, 2016, British journal of haematology.

3341 The RegiSONIC Disease Registry Study: Safety and effectiveness of vismodegib or surgery as primary treatment in patients with locally advanced basal cell carcinoma

T. Olencki, M. Lacouture, A. Sekulic, 2015 .

Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States

J. Cerhan, J. Friedberg, C. Flowers, 2015, Leukemia & lymphoma.

Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma‐related mortality in elderly follicular lymphoma in the United States

J. Cerhan, A. Zelenetz, J. Friedberg, 2015, British journal of haematology.

The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States

J. Cerhan, J. Friedberg, C. Flowers, 2014, Cancer.

Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.

J. Cerhan, A. Zelenetz, J. Friedberg, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.

J. Cerhan, A. Zelenetz, J. Friedberg, 2013 .

Managing Infusion-Related Reactions for Patients With Chronic Lymphocytic Leukemia Receiving Obinutuzumab.

M. Moran, K. Dawson, K. Guindon, 2016, Clinical journal of oncology nursing.

Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States

J. Cerhan, A. Zelenetz, J. Friedberg, 2016, American journal of hematology.

PET Compared With CT As a Prognosticator After Rituximab Induction Therapy In Follicular Lymphoma: Report From The National Lymphocare Study

A. Zelenetz, J. Friedberg, C. Flowers, 2013 .

Early Relapse Of Follicular Lymphoma After R-CHOP Uniquely Defines Patients At High Risk For Death: An Analysis From The National Lymphocare Study

A. Zelenetz, J. Friedberg, C. Flowers, 2013 .

Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma

D. Veenstra, F. Felizzi, A. Launonen, 2021, Journal of managed care & specialty pharmacy.

Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: Results of the National LymphoCare Study

J. Cerhan, J. Friedberg, C. Flowers, 2013, Cancer.

Adoption of Innovation: Impact of Rituximab (Rituxan®) Faster Infusion on Oncology Nurses' Perceptions, Practice, and Resource Utilization

K. Dawson, 2012 .

Managing Infusion-Related Reactions for Patients With Chronic Lymphocytic Leukemia Receiving Obinutuzumab.

M. Moran, K. Dawson, K. Guindon, 2016, Clinical journal of oncology nursing.

J. Cerhan, A. Zelenetz, J. Friedberg, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes following watchful waiting for stage II–IV follicular lymphoma patients in the modern era

J. Cerhan, J. Friedberg, C. Flowers, 2016, British journal of haematology.

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS).

J. Friedberg, N. Bartlett, B. Link, 2015, Blood.

Rituximab Faster Infusion for Patients With Non-Hodgkin's Lymphoma in the United States: Implications for Nursing Practice

K. Dawson, 2013, Journal of infusion nursing : the official publication of the Infusion Nurses Society.